pneumonia
one
common
infect
pediatr
age
group
one
lead
diagnos
result
overnight
hospit
admiss
children
patient
younger
year
discharg
hospit
unit
state
primari
diagnosi
pneumonia
north
america
annual
incid
pneumonia
children
younger
year
case
per
children
age
year
older
annual
incid
case
per
develop
countri
account
episod
clinic
pneumonia
worldwid
research
estim
million
new
case
occur
annual
children
younger
year
pneumonia
classifi
either
communityacquir
pneumonia
cap
nosocomi
pneumonia
hospitalacquir
pneumonia
may
ventilatorassoci
pneumonia
may
acquir
absenc
mechan
ventil
ventilatorassoci
pneumonia
differ
sever
respect
cap
address
separ
articl
although
precis
definit
univers
appli
cap
gener
defin
infect
lung
mark
symptom
acut
infect
ie
fever
cough
dyspnea
typic
associ
abnorm
auscultatori
find
eg
rale
alter
breath
sound
presenc
acut
infiltr
chest
imag
individu
hospit
resid
longterm
care
facil
least
day
onset
symptom
larg
number
microorgan
caus
pneumonia
children
tabl
list
frequent
etiolog
agent
identifi
age
group
overal
virus
respons
larg
percentag
case
cap
pediatr
age
group
particularli
common
children
age
week
year
recent
us
studi
children
age
month
year
hospit
pneumonia
found
viral
etiolog
gener
frequent
isol
respiratori
virus
respiratori
syncyti
viru
parainfluenza
virus
influenza
b
adenoviru
although
virus
may
occur
specif
set
eg
cytomegaloviru
herp
simplex
infect
neonat
case
viral
pneumonia
manag
without
invas
diagnost
test
asid
support
care
specif
antimicrobi
therapi
gener
requir
reason
remaind
articl
focus
bacteri
pneumonia
although
import
distinct
relat
viral
etiolog
highlight
appropri
epidemiolog
bacteri
cap
differ
age
impact
vaccin
strategi
birth
week
age
common
caus
pneumonia
group
b
streptococci
gramneg
rod
particularli
enter
escherichia
coli
although
virus
predomin
week
month
age
bacteri
pneumonia
occur
age
group
afebril
pneumonia
age
frequent
caus
chlamydia
trachomati
agent
rare
requir
hospit
admiss
unless
found
combin
anoth
respiratori
tract
pathogen
respiratori
syncyti
viru
pertussi
streptococcu
pneumonia
common
bacteri
caus
febril
pneumonia
among
children
age
week
year
recent
studi
texa
found
children
month
year
age
admit
pneumonia
bacteri
pathogen
isol
pneumonia
confirm
case
less
commonli
isol
bacteria
includ
haemophilu
influenza
histor
type
b
widespread
vaccin
use
current
includ
nontyp
h
influenza
streptococcu
pyogen
staphylococcu
aureu
streptococc
speci
includ
streptococcu
milleri
group
children
age
year
older
common
bacteri
pathogen
mycoplasma
pneumonia
chlamydophila
pneumonia
previous
known
chlamydia
pneumonia
atyp
agent
account
nearli
one
fourth
case
bacteri
pneumonia
among
schoolag
children
adolesc
pneumococcu
remain
high
list
agent
identifi
tabl
provid
list
less
frequent
pathogen
risk
factor
clinic
situat
prompt
consider
unusu
infect
final
import
rememb
signific
proport
case
pediatr
pneumonia
repres
mix
infect
pathogen
host
environment
factor
play
role
develop
pneumonia
typic
begin
tracheal
colon
infect
microorgan
initi
line
defens
establish
respiratori
pathogen
barrier
defens
airway
name
mucos
barrier
respiratori
epithelium
mucociliari
apparatu
respons
clear
foreign
materi
microorgan
airway
lower
respiratori
tract
inocul
suffici
burden
bacteria
normal
inflammatori
respons
fight
infect
includ
compon
antibodi
complement
phagocyt
cytokin
also
result
damag
function
lung
tissu
bacteria
commonli
caus
pneumonia
also
possess
specif
virul
factor
enhanc
surviv
propag
concurr
result
injuri
pulmonari
host
exampl
pneumonia
contain
pneumolysin
poreform
protein
enabl
bacterium
kill
host
cell
result
complement
activ
vigor
inflammatori
respons
pneumonia
also
may
result
direct
seed
lung
tissu
bacteremia
may
particularli
import
mechan
bacteria
pneumococcu
aureu
sever
studi
evalu
use
variou
clinic
symptom
sign
children
pneumonia
tachypnea
wide
shown
sensit
indic
world
health
organ
defin
tachypnea
respiratori
rate
rr
breathsmin
infant
younger
month
age
rr
breathsmin
age
month
rr
breathsmin
children
older
month
sever
studi
found
cutoff
breathsmin
children
younger
month
breathsmin
children
age
month
provid
greatest
combin
sensit
specif
identifi
children
lower
respiratori
infect
although
one
studi
show
singl
valu
breathsmin
age
equal
use
precis
predict
valu
depend
underli
preval
diseas
diagnosi
pneumonia
industri
world
rare
would
made
base
sole
presenc
tachypnea
present
mani
childhood
ill
includ
bronchiol
asthma
fever
cough
also
frequent
present
children
pneumonia
clinic
sign
may
includ
retract
abnorm
auscultatori
find
rale
decreas
breath
sound
tend
specif
indic
lower
respiratori
tract
infect
less
specif
indic
may
seen
children
includ
malais
emesi
abdomin
pain
chest
pain
particularli
suggest
bacteri
pneumonia
oppos
viral
etiolog
especi
pleurit
natur
wheez
may
seen
children
bacteri
pneumonia
suggest
bronchiol
viral
lower
respiratori
tract
infect
diagnosi
pneumonia
like
patient
present
fever
cough
tachypnea
infiltr
chest
radiographi
variou
diseas
present
similar
constel
sign
symptom
howev
differenti
diagnosi
may
includ
upper
respiratori
tract
infect
bronchiol
congest
heart
failur
pulmonari
embol
thorac
tumor
inflammatori
disord
system
vascul
among
entiti
tabl
review
diseas
consid
infiltr
present
chest
radiographi
sever
laboratori
studi
may
help
establish
diagnosi
pneumonia
children
leukocytosi
may
present
one
studi
children
present
emerg
depart
fever
white
blood
cell
count
found
occult
pneumonia
chest
radiographi
pneumonia
also
shown
common
diagnosi
children
white
blood
cell
count
even
children
white
blood
cell
count
inflammatori
marker
creactiv
protein
erythrocyt
sediment
rate
gener
elev
one
studi
found
patient
elev
creactiv
protein
like
pneumonia
proven
probabl
bacteri
caus
oppos
viral
mycoplasma
pneumonia
cultur
blood
bacteria
tradit
recommend
consensu
guidelin
diagnosi
manag
pneumonia
particularli
bacteri
caus
suspect
recommend
stem
previou
work
suggest
rate
bacteremia
adult
hospit
pneumonia
rang
sever
recent
studi
attempt
evalu
use
blood
cultur
diagnosi
pneumonia
howev
studi
yield
blood
cultur
lowergener
rang
manag
pneumonia
rare
alter
variou
organ
may
detect
pneumonia
frequent
isol
pathogen
studi
like
current
rate
bacteremia
lower
introduct
pneumococc
conjug
vaccin
routin
childhood
immun
schedul
increas
resist
antimicrobi
agent
limit
avail
data
regard
use
cultur
blood
among
children
pneumonia
sinc
widespread
use
conjug
pneumococc
vaccin
feel
patient
diseas
sever
enough
requir
hospit
admiss
parenter
antimicrobi
therapi
gener
cultur
blood
sent
therapi
although
uncommon
identifi
pathogen
identif
specif
organ
pneumonia
aureu
associ
antimicrobi
suscept
help
especi
sever
case
pleural
effus
present
sever
microbiolog
test
consid
diagnost
aid
cultur
sputum
variabl
use
publish
studi
yield
rang
consid
reliabl
ie
bronchial
origin
oppos
oropharyng
sputum
sampl
contain
fewer
ten
epitheli
cell
per
lowpow
field
difficult
obtain
good
sputum
sampl
children
often
nonproduct
cough
gener
valuabl
sampl
expector
sputum
difficult
obtain
preschoolag
child
although
sputum
gram
stain
singl
predomin
organ
leukocyt
epitheli
cell
help
neg
gram
stain
result
never
exclud
pneumonia
possibl
diagnosi
pneumococc
urinari
antigen
test
gener
recommend
diagnost
modal
pediatr
pneumonia
despit
good
sensit
specif
test
low
frequent
posit
individu
nasopharyng
colon
particularli
young
children
viral
diagnost
either
cultur
antigen
detect
use
direct
fluoresc
antibodi
necessari
routin
pneumonia
case
use
certain
circumst
includ
case
involv
immunocompromis
patient
help
guid
infect
control
precaut
mycoplasma
infect
identifi
use
serolog
posit
igm
indic
acut
infect
polymeras
chain
reaction
test
also
avail
higher
sensit
specif
rare
necessari
outsid
research
set
c
pneumonia
may
detect
rapidli
direct
fluoresc
antibodi
nasopharyng
specimen
diagnos
serolog
legionella
urinari
antigen
diagnost
modal
choic
legionella
pneumophila
infect
suspect
test
remain
posit
week
acut
infect
import
rememb
urinari
antigen
neg
case
involv
speci
legionella
decis
perform
skin
test
purifi
protein
deriv
patient
present
pneumonia
base
presenc
risk
factor
would
increas
likelihood
tuberculosi
specif
radiograph
find
suggest
mycobacteri
diseas
presenc
mediastin
adenopathi
diagnosi
pneumonia
frequent
made
confirm
presenc
consolid
infiltr
chest
radiographi
presenc
respiratori
sign
eg
cough
tachypnea
rale
increas
likelihood
posit
chest
radiograph
one
metaanalysi
suggest
infant
younger
month
age
temperatur
f
higher
clinic
find
pulmonari
diseas
defin
rale
ronchi
retract
wheez
tachypnea
coryza
grunt
stridor
nasal
flare
cough
requir
routin
chest
radiographi
probabl
normal
chest
radiograph
absenc
find
least
chest
radiograph
obtain
patient
pneumonia
variou
pattern
may
seen
alveolar
infiltr
seen
frequent
bacteri
pneumonia
wherea
viral
infect
frequent
associ
interstiti
pattern
distinct
univers
howev
studi
confirm
patient
viral
pneumonia
present
infiltr
lobar
alveolar
appear
interobserv
agreement
among
radiologist
pattern
infiltr
alveolar
versu
interstiti
presenc
air
bronchogram
also
demonstr
poor
one
interest
studi
show
radiologist
read
chest
radiograph
febril
children
age
month
bias
read
treat
physician
compar
radiologist
access
inform
mycoplasma
pneumonia
appear
commonli
unilater
bilater
area
airspac
consolid
includ
reticular
nodular
opac
highresolut
ct
groundglass
opac
airspac
consolid
nodul
bronchovascular
thicken
common
children
exhibit
persist
progress
symptom
despit
seemingli
adequ
therapi
contrastenhanc
chest
ct
use
detect
suppur
complic
empyema
necrosi
may
requir
intervent
adult
cap
predict
rule
pneumonia
sever
index
develop
valid
identifi
patient
low
risk
death
advers
outcom
might
treat
success
outpati
score
creat
use
variou
criteria
assess
initi
present
includ
demograph
factor
eg
age
sex
nurs
home
resid
coexist
ill
eg
neoplast
diseas
congest
heart
failur
cerebrovascular
diseas
renal
diseas
liver
diseas
physic
examin
find
eg
mental
statu
rr
heart
rate
blood
pressur
temperatur
laboratori
radiograph
find
eg
arteri
ph
blood
urea
nitrogen
sodium
glucos
hematocrit
partial
pressur
arteri
oxygen
pleural
effus
patient
place
specif
risk
class
guid
decis
need
hospit
similar
tool
pediatr
patient
would
use
valid
score
system
establish
although
specif
admiss
criteria
children
may
vari
among
institut
sever
criteria
admiss
wide
use
includ
ill
appear
septic
physiolog
hypoxia
requir
oxygen
administr
moder
sever
respiratori
distress
inabl
toler
oral
fluid
medic
social
factor
absenc
telephon
inabl
followup
pediatrician
return
emerg
depart
diseas
worsen
neonat
febril
pneumonia
gener
manag
inpati
although
one
field
studi
india
suggest
infant
could
treat
safe
commun
first
month
life
patient
underli
condit
could
affect
clinic
cours
advers
children
complic
pneumonia
admit
initi
therapi
like
etiolog
agent
depend
age
child
logic
select
initi
empir
antibiot
regimen
accord
age
neonat
birth
week
age
group
b
streptococcu
gramneg
rod
predomin
initi
coverag
intraven
iv
ampicillin
gentamicin
case
diseas
sever
thirdgener
cephalosporin
eg
cefotaxim
may
ad
continu
ampicillin
cover
listeria
monocytogen
anoth
pathogen
age
group
age
week
month
infant
afebril
erythromycin
mgkgd
iv
divid
everi
hour
drug
choic
treatment
c
trachomati
fever
present
child
seem
ill
ceftriaxon
mgkgd
everi
hour
given
patient
age
month
year
viral
pneumonia
common
caus
suspect
antibiot
therapi
administ
bacteri
pneumonia
suspect
iv
ampicillin
mgkgd
divid
everi
hour
use
child
appear
ill
ceftriaxon
may
chosen
instead
provid
broader
coverag
final
among
children
age
year
older
azithromycin
one
dose
mgkg
follow
mgkgd
erythromycin
use
routin
case
provid
coverag
atyp
organ
particularli
mycoplasma
ampicillin
may
ad
strong
evid
bacteri
etiolog
ceftriaxon
without
macrolid
may
use
children
ill
age
featur
suggest
aureu
present
oxacillin
vancomycin
ad
depend
preval
methicillinresist
staphylococcu
commun
specif
pathogen
identifi
coverag
narrow
accordingli
chlamydia
mycoplasma
infect
macrolid
dose
describ
previous
drug
choic
patient
suspect
pneumococc
pneumonia
therapeut
choic
driven
local
antimicrobi
suscept
pattern
pneumonia
recov
appropri
patient
specimen
antibiot
suscept
pattern
use
guid
therapi
isol
fulli
suscept
penicillin
minim
inhibitori
concentr
b
mgml
ampicillin
administ
easier
dose
schedul
compar
penicillin
even
isol
intermedi
suscept
penicillin
minim
inhibitori
concentr
mgml
highdos
ampicillin
mgkgd
provid
excel
coverag
fulli
nonsuscept
isol
encount
minim
inhibitori
concentr
mgml
ceftriaxon
use
unlik
treatment
mening
vancomycin
rare
necessari
treatment
pneumococc
pneumonia
even
penicillin
nonsuscept
strain
etiolog
agent
ad
ceftriaxon
resist
defin
pneumonia
minim
inhibitori
concentr
mgml
demonstr
recent
studi
spain
suggest
combin
betalactam
plu
macrolid
may
superior
betalactam
alon
treatment
pneumococc
pneumonia
adult
random
trial
address
hypothesi
publish
date
h
influenza
consid
like
pathogen
children
underli
lung
diseas
ceftriaxon
ampicillinsulbactam
prefer
rather
ampicillin
presenc
betalactamasemedi
ampicillin
resist
among
mani
h
influenza
isol
optim
length
antimicrobi
therapi
treatment
uncompl
complic
pneumonia
well
establish
pathogen
data
suggest
cours
therapi
cours
azithromycin
adequ
treatment
c
pneumonia
pneumococc
pneumonia
treatment
probabl
continu
patient
afebril
hour
total
durat
therapi
probabl
less
day
day
use
azithromycin
long
tissu
halflif
fever
may
persist
sever
day
initi
appropri
therapi
reflect
result
inflammatori
cascad
tissu
damag
good
data
avail
support
prolong
treatment
cours
patient
without
underli
condit
eg
cystic
fibrosi
uncompl
pneumonia
data
suggest
shorter
cours
therapi
may
equival
current
standard
although
control
studi
need
practic
recommend
routin
sever
group
publish
practic
guidelin
manag
cap
adult
analog
clinic
practic
guidelin
pediatr
pneumonia
accept
univers
although
sever
suggest
guidelin
publish
despit
differ
among
variou
recommend
guidelin
serv
excel
compil
exist
evid
regard
multipl
aspect
treatment
pneumonia
differ
recommend
manag
strategi
contribut
variat
care
diagnosi
howev
publish
studi
adult
patient
cap
shown
adher
treatment
guidelin
result
improv
sever
outcom
includ
lower
cost
decreas
length
stay
appropri
antibiot
usag
lower
mortal
rate
even
guidelin
use
physician
impress
adher
clinic
practic
guidelin
alway
match
actual
adher
recommend
contain
therein
suggest
awar
guarante
familiar
caus
organ
case
pneumonia
frequent
identifi
sputum
examin
blood
cultur
symptom
persist
despit
empir
antibiot
therapi
bronchoscopi
bronchoalveolar
lavag
bal
diagnost
option
sever
studi
shown
cultur
bal
fluid
children
pneumonia
use
make
microbiolog
diagnosi
although
bronchoscopi
necessari
routin
case
consid
patient
fail
improv
standard
therapi
concern
antibiot
resist
unusu
organ
high
recoveri
caus
agent
chang
manag
earli
bronchoscopi
may
critic
immunocompromis
patient
select
empir
therapi
difficult
expand
list
potenti
caus
singl
set
criteria
defin
clinic
stabil
inpati
pneumonia
gain
widespread
accept
introduc
variabl
decis
discharg
combin
normal
vital
sign
abil
take
oral
nutrit
clear
mental
statu
shown
predict
low
risk
subsequ
clinic
deterior
among
hospit
adult
pneumonia
time
clinic
stabil
postadmiss
mortal
suggest
reliabl
clinic
base
outcom
measur
cap
along
processofcar
measur
admissiontoantibiot
time
proport
patient
receiv
guidelinebas
antibiot
therapi
percentag
patient
switch
iv
oral
therapi
within
hour
reach
clinic
stabil
followup
children
pneumonia
discharg
hospit
includ
involv
pediatrician
primari
care
provid
ensur
clinic
stabil
continu
antibiot
therapi
complet
prescrib
otherwis
healthi
children
followup
radiograph
studi
necessari
singl
episod
pneumonia
consolid
chest
radiograph
persist
week
regardless
clinic
improv
children
pneumonia
infect
found
detect
abnorm
highresolut
ct
scan
year
episod
followup
radiograph
reserv
children
underli
condit
recurr
persist
symptom
recurr
episod
pneumonia
case
period
least
week
recommend
obtain
followup
radiograph
although
rate
hospit
pneumonia
among
children
rise
mortal
rate
childhood
pneumonia
unit
state
declin
death
pneumonia
death
case
fatal
rate
adjust
underli
comorbid
estim
children
younger
year
age
children
age
year
although
antibiot
use
probabl
account
much
decreas
mortal
rate
earli
part
time
period
recent
declin
like
attribut
part
improv
access
care
poor
children
improv
critic
care
medicin
also
may
reduc
mortal
highest
children
underli
medic
condit
children
develop
pneumonia
longterm
sequela
data
suggest
children
may
symptom
asthma
year
hospit
pneumonia
howev
may
reflect
either
unrecogn
asthma
time
present
cap
propens
develop
asthma
cap
parapneumon
effus
uncommon
pneumonia
occur
conjunct
etiolog
agent
wherea
pneumonia
account
case
parapneumon
effus
aureu
pyogen
associ
particularli
high
rate
effus
empyema
tuberculosi
also
common
caus
geograph
area
high
preval
diseas
consid
differenti
diagnosi
select
patient
tradit
classif
effus
transud
versu
empyema
base
laboratori
analysi
pleural
fluid
characterist
suggest
empyema
includ
ph
less
lactat
dehydrogenas
iuml
glucos
less
mgdl
addit
data
may
obtain
includ
elev
pleural
fluid
white
blood
cell
count
ie
n
posit
microbiolog
studi
includ
gram
stain
cultur
diagnost
test
stain
polymeras
chain
reaction
pleural
fluid
cell
count
limit
predict
valu
howev
posit
microbiolog
diagnosi
made
pleural
fluid
analysi
less
one
third
case
ct
scan
find
pleural
thicken
enhanc
among
other
shown
inaccur
predict
effus
meet
laboratori
criteria
empyema
sever
therapeut
option
avail
manag
parapneumon
effus
antibiot
therapi
alon
may
result
resolut
case
drainag
fluid
thoracentesi
placement
drainag
tube
largebor
chest
tube
pigtail
cathet
remov
effus
one
studi
found
either
needl
aspir
alon
cathet
drainag
result
similar
complic
rate
length
stay
children
underw
primari
aspir
without
cathet
placement
higher
reintervent
rate
children
cathet
placement
time
initi
drainag
lower
ph
especi
b
presenc
locul
also
independ
predictor
reintervent
studi
natur
histori
parapneumon
effus
follow
sever
stage
begin
exud
phase
fluid
freeflow
low
cellular
stage
follow
hour
later
fibropurul
phase
accumul
fibrin
neutrophil
may
result
locul
final
organ
phase
occur
fibroblast
activ
result
format
peel
thoracoscopi
surgic
may
necessari
effus
longstand
enough
allow
develop
septat
reduc
feasibl
tube
drainag
surgeri
shown
reduc
length
stay
hospit
children
whose
effus
consid
high
grade
defin
contain
sonograph
evid
organ
frond
septat
locul
particular
videoassist
thoracoscop
surgeri
shown
numer
advantag
compar
open
thoracotomi
includ
fewer
lung
resect
fewer
associ
blood
transfus
less
postop
analgesia
shorter
length
stay
faster
resolut
fever
shorter
time
remov
chest
drain
altern
option
manag
locul
parapneumon
effus
use
intrapleur
fibrinolyt
agent
tissu
plasminogen
activ
streptokinas
urokinas
agent
use
inadequ
drainag
obtain
chest
tube
insert
recent
report
fibrinolyt
therapi
children
demonstr
effus
fibropurul
phase
drain
complet
anoth
drain
partial
use
techniqu
daili
instil
streptokinas
urokinas
chest
tube
dwell
time
hour
techniqu
ineffect
drain
effus
alreadi
reach
organ
phase
howev
increas
drainag
also
demonstr
use
dwell
tissu
plasminogen
activ
one
random
trial
children
show
children
receiv
intrapleur
urokinas
treatment
shorter
length
stay
compar
placebo
group
fibrinolyt
therapi
associ
sever
rare
complic
includ
allerg
reaction
particularli
streptokinas
hemorrhag
bronchopleur
fistula
format
larg
prospect
random
trial
need
defin
better
sever
aspect
treatment
option
includ
precis
indic
optim
dose
durat
therapi
complic
rate
failur
improv
despit
appropri
antimicrobi
therapi
rais
suspicion
complic
parenchym
necrosi
abscess
complic
may
identifi
contrastenhanc
ct
scan
plain
film
reveal
find
decreas
parenchym
enhanc
may
herald
develop
cavitari
necrosi
prolong
intens
ill
children
develop
cavitari
necrosi
eventu
demonstr
resolut
pulmonari
abnorm
followup
radiographi
howev
even
absenc
surgic
intervent
intervent
procedur
eg
percutan
cathet
placement
avoid
children
necrot
pneumonia
procedur
may
increas
likelihood
complic
bronchopleur
fistula
format
lung
abscess
uncommon
complic
frequent
occur
older
children
abscess
may
primari
secondari
expert
recommend
therapi
routin
includ
coverag
gramposit
organ
aureu
streptococci
anaerob
although
gramneg
coverag
may
requir
select
circumst
patient
treat
medic
needl
aspir
percutan
cathet
drainag
abscess
safe
often
provid
diagnost
therapeut
valu
case
fail
resolv
antibiot
therapi
alon
without
associ
complic
rate
seen
necrot
pneumonia
gener
percutan
drainag
consid
patient
condit
worsen
clinic
statu
fail
improv
hour
antibiot
therapi
least
week
iv
antibiot
therapi
deliv
lobectomi
consid
recurr
pneumonia
gener
defin
two
episod
year
three
episod
lifetim
children
recurr
pneumonia
identifi
underli
predispos
factor
one
pediatr
studi
common
factor
aspir
secondari
oropharyng
muscular
incoordin
eg
cerebr
palsi
identifi
ill
includ
immun
disord
gener
relat
malign
abnorm
humor
immun
system
includ
hiv
infect
congenit
heart
diseas
asthma
congenit
acquir
anatom
abnorm
eg
tracheoesophag
fistula
gastroesophag
reflux
sickl
cell
anemia
evalu
child
recurr
pneumonia
includ
detail
histori
focus
possibl
indic
underli
ill
combin
target
diagnost
evalu
may
includ
test
swallow
studi
serum
immunoglobulin
hiv
test
echocardiographi
pulmonari
function
test
sweat
test
radiograph
studi
chest
ct
sever
underli
abnorm
may
result
predisposit
develop
pneumonia
patient
endotrach
tube
tracheostomi
risk
lower
respiratori
tract
infect
aspir
contamin
secret
oropharynx
stomach
enhanc
sever
factor
includ
pool
secret
cuff
subsequ
leak
prolong
supin
posit
intub
patient
intens
care
unit
may
fever
respiratori
compromis
unrel
lung
infect
distinguish
bacteri
colon
tracheal
aspir
pneumonia
difficult
ventilatorassoci
pneumonia
best
identifi
use
combin
diagnost
modal
one
studi
ventil
children
bacteri
pneumonia
met
one
follow
three
criteria
bronchoscop
protect
specimen
brush
cultur
colonyform
unitsml
intracellular
bacteria
cell
retriev
bal
bal
fluid
cultur
colonyform
unitsml
patient
gastroesophag
reflux
patient
unabl
control
secret
neurolog
impair
underli
drug
induc
anatom
disrupt
risk
aspir
pneumonia
aspir
oropharyng
content
may
produc
chemic
pneumon
frequent
difficult
assess
whether
introduct
oral
bacteria
result
establish
lower
respiratori
tract
infect
antibiot
therapi
routin
prescrib
presum
aspir
pneumonia
administr
either
penicillin
clindamycin
provid
reason
coverag
oral
anaerob
shown
equal
effect
therapi
indic
children
experi
aspir
event
hospit
other
infect
pseudomona
gramneg
organ
suspect
eg
patient
cystic
fibrosi
combin
agent
ampicillin
piperacillin
betalactamas
inhibitor
consid
abnorm
host
immun
system
may
predispos
child
develop
pneumonia
common
scenario
seen
hospit
patient
includ
malign
either
hematolog
solid
tumor
solid
organ
stem
cell
transplant
congenit
acquir
immunodefici
autoimmun
disord
immunosuppress
medic
use
treat
system
ill
regardless
caus
immunocompromis
host
consid
high
risk
infect
merit
aggress
diagnost
therapeut
approach
tabl
review
microorgan
may
pathogen
immunocompromis
patient
pneumonia
particular
viral
infect
especi
cytomegaloviru
fungal
infect
includ
candida
aspergillu
must
consid
along
unusu
organ
pneumocysti
jaroveci
formerli
known
pneumocysti
carinii
cryptococcu
neoforman
result
chest
radiograph
patient
neutropenia
may
neg
although
find
suggest
infecti
caus
nodul
may
visibl
plain
film
chest
ct
scan
may
demonstr
abnorm
detect
routin
radiograph
may
help
local
lesion
particularli
nodul
amen
biopsi
aid
diagnosi
mr
imag
anoth
altern
diagnost
modal
may
sensit
detect
necrot
pneumonia
ct
scan
flexibl
bronchoscopi
establish
diagnosi
mani
case
sever
sampl
method
avail
one
studi
immunocompromis
patient
diagnost
yield
highest
use
combin
bal
transbronchi
biopsi
compar
bal
alon
transbronchi
biopsi
alon
protect
specimen
brush
sampl
final
lung
biopsi
may
consid
assist
make
diagnosi
patient
concern
clinic
statu
noninvas
test
fail
uncov
etiolog
agent
gener
decis
regard
diagnost
test
may
need
acceler
popul
patient
permit
intervent
perform
clinic
statu
deterior
patient
unabl
toler
invas
procedur
allow
appropri
therapi
initi
earlier
cours
diseas
differenti
diagnosi
pneumonia
patient
hospit
prolong
period
includ
routin
infecti
etiolog
hospitalacquir
organ
failur
improv
appropri
empir
therapi
rais
concern
antimicrobi
resist
organ
particular
import
situat
may
includ
methicillinresist
aureu
vancomycinresist
enterococci
gramneg
rod
resist
thirdgener
cephalosporin
among
other
empir
coverag
pneumonia
patient
intens
care
unit
other
risk
nosocomi
infect
includ
broadspectrum
agent
provid
coverag
antibioticresist
organ
organ
known
frequent
caus
hospitalacquir
infect
institut
specif
diagnosi
made
antimicrobi
suscept
avail
infect
control
staff
hospit
microbiolog
laboratori
invalu
resourc
determin
organ
consid
circumst
isol
precaut
topic
particular
interest
hospitalist
manag
patient
pneumonia
particularli
specif
etiolog
agent
identifi
pneumonia
caus
wide
varieti
agent
sever
differ
infect
control
precaut
may
appropri
singl
import
procedur
prevent
spread
infect
hospit
hand
hygien
perform
either
soap
water
waterless
alcoholbas
hand
sanit
tabl
review
correct
precaut
specif
organ
may
encount
hospit
set
two
infect
merit
specif
mention
pertussi
influenza
organ
highli
infecti
exposur
among
hospit
staff
may
requir
chemoprophylaxi
patient
pertussi
influenza
admit
singl
room
whenev
possibl
staff
also
wear
mask
enter
room
patient
influenza
despit
fact
droplet
transmiss
precaut
usual
requir
mask
within
feet
sever
report
suggest
role
airborn
transmiss
pulmonari
tuberculosi
suspect
strict
attent
airborn
precaut
must
follow
addit
use
respir
negativepressur
isol
room
visit
limit
possibl
institut
two
primari
visitor
may
undergo
screen
chest
radiographi
ensur
activ
pulmonari
infect
special
organ
precaut
contact
refer
gown
glove
droplet
refer
mask
within
feet
airborn
refer
respir
enter
room
special
organ
precaut
refer
gown
glove
dedic
patient
equip
medic
care
complex
patient
increasingli
shift
inpati
outpati
arena
greater
number
infect
treat
continu
deliveri
parenter
antibiot
therapi
home
stepdown
facil
outpati
parenter
antimicrobi
therapi
opat
reason
option
patient
pneumonia
stabil
clinic
hospit
judg
requir
prolong
parenter
treatment
treatment
lower
respiratori
tract
infect
use
opat
result
excel
clinic
outcom
high
level
patient
physician
satisfact
elig
opat
requir
suitabl
home
environ
select
antimicrobi
agent
appropri
pharmacokinet
paramet
drug
stabil
allow
reason
dose
schedul
home
infecti
diseas
specialist
physician
knowledg
use
antimicrobi
agent
opat
hospit
pharmacist
involv
discharg
plan
administr
opat
involv
discharg
plan
servic
hospit
also
facilit
contact
visit
nurs
associ
arrang
instruct
famili
proper
techniqu
iv
infus
home
agenc
make
home
visit
observ
caregiv
answer
question
obtain
blood
laboratori
monitor
diseas
medic
toxic
use
servic
conjunct
care
followup
primari
care
physician
provid
best
continu
care
hospit
outpati
set
help
ensur
patient
pneumonia
receiv
highest
qualiti
care
across
health
care
spectrum
